This inventor holds 3 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Kyoto University, Stem Cell & Device Laboratory, Inc.. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2023
Title: Kazuhiro Aiba: Innovator in Neural Activity and Amyotrophic Lateral Sclerosis Research
Introduction
Kazuhiro Aiba is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the fields of neuroscience and medical research, particularly in the development of devices and pharmaceutical compositions aimed at understanding and treating neurological conditions. With a total of 3 patents, Aiba's work is at the forefront of innovation in neural activity evaluation and amyotrophic lateral sclerosis (ALS) treatment.
Latest Patents
One of Aiba's latest patents is a nerve cell device and method for evaluating neural activity. This invention allows for early observation of nerve activity, such as spikes and bursts, by cultivating neurons on a cell scaffold. The device enhances the measured electric strength, enabling imaging of intracellular signaling. Another significant patent is a pharmaceutical composition for the prevention and treatment of amyotrophic lateral sclerosis. This invention provides a prophylactic or therapeutic agent containing a 1,3-diphenylurea derivative or multikinase inhibitor, offering new hope for ALS patients.
Career Highlights
Kazuhiro Aiba has worked with esteemed institutions such as Kyoto University and Stem Cell & Device Laboratory, Inc. His research has focused on advancing the understanding of neural mechanisms and developing innovative solutions for neurological disorders. His dedication to scientific inquiry and innovation has positioned him as a key figure in his field.
Collaborations
Aiba has collaborated with notable colleagues, including Norio Nakatsuji and Motonari Uesugi. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in neuroscience.
Conclusion
Kazuhiro Aiba's contributions to the fields of neural activity and ALS research exemplify the impact of innovation in medicine. His patents reflect a commitment to advancing scientific knowledge and improving patient outcomes. Aiba's work continues to inspire future research and development in these critical areas.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile